Pharmaceuticals

United States Active Pharma Ingredient Market Report 2017

  • QYR1563857
  • 118 Pages
  • September 2017
  • Pharmaceuticals
Download Sample    Get Discount   
 
In this report, the United States Active Pharma Ingredient market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:

The West

Southwest

The Middle Atlantic

New England

The South

The Midwest

with sales (volume), revenue (value), market share and growth rate of Active Pharma Ingredient in these regions, from 2012 to 2022 (forecast).

United States Active Pharma Ingredient market competition by top manufacturers/players, with Active Pharma Ingredient sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including

Teva

Novartis

Pfizer

Johnson & Johnson

Mylan

North China Pharmaceutical Group

Dr. Reddy’s Laboratories

Roche

Aurobindo pharma

Sun Pharmaceutical Industries

Boehringer Ingelheim GmbH

Bayer

BASF

DSM

Zhejiang Medicine

Biocon

Johnson Matthey

Hisun Pharmacy

Cambrex

Shandong Xinhua Pharmaceutical

Lonza group

Huahai Pharmaceutical

Haerbin Pharmaceutical Group

Cipla

Tian Yao

Lupin

North East Pharmaceutical

Albemarle

Shandong Lukang Pharmaceutical

Jiangsu Hengrui Medicine

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into

Innovative Active Pharmaceutical Ingredients

Generic Active Pharmaceutical Ingredients

On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Active Pharma Ingredient for each application, including

Oncology

Cardiovascular Disease

Diabetes

Central Nervous System and Neurological Disorders

Endocrinology

Other Therapeutic Applications

If you have any special requirements, please let us know and we will offer you the report as you want.

Table of Contents

United States Active Pharma Ingredient Market Report 2017

1 Active Pharma Ingredient Overview

1.1 Product Overview and Scope of Active Pharma Ingredient

1.2 Classification of Active Pharma Ingredient by Product Category

1.2.1 United States Active Pharma Ingredient Market Size (Sales Volume) Comparison by Type (2012-2022)

1.2.2 United States Active Pharma Ingredient Market Size (Sales Volume) Market Share by Type (Product Category) in 2016

1.2.3 Innovative Active Pharmaceutical Ingredients

1.2.4 Generic Active Pharmaceutical Ingredients

1.3 United States Active Pharma Ingredient Market by Application/End Users

1.3.1 United States Active Pharma Ingredient Market Size (Consumption) and Market Share Comparison by Application (2012-2022)

1.3.2 Oncology

1.3.3 Cardiovascular Disease

1.3.4 Diabetes

1.3.5 Central Nervous System and Neurological Disorders

1.3.6 Endocrinology

1.3.7 Other Therapeutic Applications

1.4 United States Active Pharma Ingredient Market by Region

1.4.1 United States Active Pharma Ingredient Market Size (Value) Comparison by Region (2012-2022)

1.4.2 The West Active Pharma Ingredient Status and Prospect (2012-2022)

1.4.3 Southwest Active Pharma Ingredient Status and Prospect (2012-2022)

1.4.4 The Middle Atlantic Active Pharma Ingredient Status and Prospect (2012-2022)

1.4.5 New England Active Pharma Ingredient Status and Prospect (2012-2022)

1.4.6 The South Active Pharma Ingredient Status and Prospect (2012-2022)

1.4.7 The Midwest Active Pharma Ingredient Status and Prospect (2012-2022)

1.5 United States Market Size (Value and Volume) of Active Pharma Ingredient (2012-2022)

1.5.1 United States Active Pharma Ingredient Sales and Growth Rate (2012-2022)

1.5.2 United States Active Pharma Ingredient Revenue and Growth Rate (2012-2022)

2 United States Active Pharma Ingredient Market Competition by Players/Suppliers

2.1 United States Active Pharma Ingredient Sales and Market Share of Key Players/Suppliers (2012-2017)

2.2 United States Active Pharma Ingredient Revenue and Share by Players/Suppliers (2012-2017)

2.3 United States Active Pharma Ingredient Average Price by Players/Suppliers (2012-2017)

2.4 United States Active Pharma Ingredient Market Competitive Situation and Trends

2.4.1 United States Active Pharma Ingredient Market Concentration Rate

2.4.2 United States Active Pharma Ingredient Market Share of Top 3 and Top 5 Players/Suppliers

2.4.3 Mergers & Acquisitions, Expansion in United States Market

2.5 United States Players/Suppliers Active Pharma Ingredient Manufacturing Base Distribution, Sales Area, Product Type

3 United States Active Pharma Ingredient Sales (Volume) and Revenue (Value) by Region (2012-2017)

3.1 United States Active Pharma Ingredient Sales and Market Share by Region (2012-2017)

3.2 United States Active Pharma Ingredient Revenue and Market Share by Region (2012-2017)

3.3 United States Active Pharma Ingredient Price by Region (2012-2017)

4 United States Active Pharma Ingredient Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)

4.1 United States Active Pharma Ingredient Sales and Market Share by Type (Product Category) (2012-2017)

4.2 United States Active Pharma Ingredient Revenue and Market Share by Type (2012-2017)

4.3 United States Active Pharma Ingredient Price by Type (2012-2017)

4.4 United States Active Pharma Ingredient Sales Growth Rate by Type (2012-2017)

5 United States Active Pharma Ingredient Sales (Volume) by Application (2012-2017)

5.1 United States Active Pharma Ingredient Sales and Market Share by Application (2012-2017)

5.2 United States Active Pharma Ingredient Sales Growth Rate by Application (2012-2017)

5.3 Market Drivers and Opportunities

6 United States Active Pharma Ingredient Players/Suppliers Profiles and Sales Data

6.1 Teva

6.1.1 Company Basic Information, Manufacturing Base and Competitors

6.1.2 Active Pharma Ingredient Product Category, Application and Specification

6.1.2.1 Product A

6.1.2.2 Product B

6.1.3 Teva Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)

6.1.4 Main Business/Business Overview

6.2 Novartis

6.2.2 Active Pharma Ingredient Product Category, Application and Specification

6.2.2.1 Product A

6.2.2.2 Product B

6.2.3 Novartis Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)

6.2.4 Main Business/Business Overview

6.3 Pfizer

6.3.2 Active Pharma Ingredient Product Category, Application and Specification

6.3.2.1 Product A

6.3.2.2 Product B

6.3.3 Pfizer Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)

6.3.4 Main Business/Business Overview

6.4 Johnson & Johnson

6.4.2 Active Pharma Ingredient Product Category, Application and Specification

6.4.2.1 Product A

6.4.2.2 Product B

6.4.3 Johnson & Johnson Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)

6.4.4 Main Business/Business Overview

6.5 Mylan

6.5.2 Active Pharma Ingredient Product Category, Application and Specification

6.5.2.1 Product A

6.5.2.2 Product B

6.5.3 Mylan Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)

6.5.4 Main Business/Business Overview

6.6 North China Pharmaceutical Group

6.6.2 Active Pharma Ingredient Product Category, Application and Specification

6.6.2.1 Product A

6.6.2.2 Product B

6.6.3 North China Pharmaceutical Group Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)

6.6.4 Main Business/Business Overview

6.7 Dr. Reddy’s Laboratories

6.7.2 Active Pharma Ingredient Product Category, Application and Specification

6.7.2.1 Product A

6.7.2.2 Product B

6.7.3 Dr. Reddy’s Laboratories Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)

6.7.4 Main Business/Business Overview

6.8 Roche

6.8.2 Active Pharma Ingredient Product Category, Application and Specification

6.8.2.1 Product A

6.8.2.2 Product B

6.8.3 Roche Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)

6.8.4 Main Business/Business Overview

6.9 Aurobindo pharma

6.9.2 Active Pharma Ingredient Product Category, Application and Specification

6.9.2.1 Product A

6.9.2.2 Product B

6.9.3 Aurobindo pharma Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)

6.9.4 Main Business/Business Overview

6.10 Sun Pharmaceutical Industries

6.10.2 Active Pharma Ingredient Product Category, Application and Specification

6.10.2.1 Product A

6.10.2.2 Product B

6.10.3 Sun Pharmaceutical Industries Active Pharma Ingredient Sales, Revenue, Price and Gross Margin (2012-2017)

6.10.4 Main Business/Business Overview

6.11 Boehringer Ingelheim GmbH

6.12 Bayer

6.13 BASF

6.14 DSM

6.15 Zhejiang Medicine

6.16 Biocon

6.17 Johnson Matthey

6.18 Hisun Pharmacy

6.19 Cambrex

6.20 Shandong Xinhua Pharmaceutical

6.21 Lonza group

6.22 Huahai Pharmaceutical

6.23 Haerbin Pharmaceutical Group

6.24 Cipla

6.25 Tian Yao

6.26 Lupin

6.27 North East Pharmaceutical

6.28 Albemarle

6.29 Shandong Lukang Pharmaceutical

6.30 Jiangsu Hengrui Medicine

7 Active Pharma Ingredient Manufacturing Cost Analysis

7.1 Active Pharma Ingredient Key Raw Materials Analysis

7.1.1 Key Raw Materials

7.1.2 Price Trend of Key Raw Materials

7.1.3 Key Suppliers of Raw Materials

7.1.4 Market Concentration Rate of Raw Materials

7.2 Proportion of Manufacturing Cost Structure

7.2.1 Raw Materials

7.2.2 Labor Cost

7.2.3 Manufacturing Expenses

7.3 Manufacturing Process Analysis of Active Pharma Ingredient

8 Industrial Chain, Sourcing Strategy and Downstream Buyers

8.1 Active Pharma Ingredient Industrial Chain Analysis

8.2 Upstream Raw Materials Sourcing

8.3 Raw Materials Sources of Active Pharma Ingredient Major Manufacturers in 2016

8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders

9.1 Marketing Channel

9.1.1 Direct Marketing

9.1.2 Indirect Marketing

9.1.3 Marketing Channel Development Trend

9.2 Market Positioning

9.2.1 Pricing Strategy

9.2.2 Brand Strategy

9.2.3 Target Client

9.3 Distributors/Traders List

10 Market Effect Factors Analysis

10.1 Technology Progress/Risk

10.1.1 Substitutes Threat

10.1.2 Technology Progress in Related Industry

10.2 Consumer Needs/Customer Preference Change

10.3 Economic/Political Environmental Change

11 United States Active Pharma Ingredient Market Size (Value and Volume) Forecast (2017-2022)

11.1 United States Active Pharma Ingredient Sales Volume, Revenue Forecast (2017-2022)

11.2 United States Active Pharma Ingredient Sales Volume Forecast by Type (2017-2022)

11.3 United States Active Pharma Ingredient Sales Volume Forecast by Application (2017-2022)

11.4 United States Active Pharma Ingredient Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix

13.1 Methodology/Research Approach

13.1.1 Research Programs/Design

13.1.2 Market Size Estimation

13.1.3 Market Breakdown and Data Triangulation

13.2 Data Source

13.2.1 Secondary Sources

13.2.2 Primary Sources

13.3 Disclaimer

List of Tables and Figures

Figure Product Picture of Active Pharma Ingredient

Figure United States Active Pharma Ingredient Market Size (K Units) by Type (2012-2022)

Figure United States Active Pharma Ingredient Sales Volume Market Share by Type (Product Category) in 2016

Figure Innovative Active Pharmaceutical Ingredients Product Picture

Figure Generic Active Pharmaceutical Ingredients Product Picture

Figure United States Active Pharma Ingredient Market Size (K Units) by Application (2012-2022)

Figure United States Sales Market Share of Active Pharma Ingredient by Application in 2016

Figure Oncology Examples

Table Key Downstream Customer in Oncology

Figure Cardiovascular Disease Examples

Table Key Downstream Customer in Cardiovascular Disease

Figure Diabetes Examples

Table Key Downstream Customer in Diabetes

Figure Central Nervous System and Neurological Disorders Examples

Table Key Downstream Customer in Central Nervous System and Neurological Disorders

Figure Endocrinology Examples

Table Key Downstream Customer in Endocrinology

Figure Other Therapeutic Applications Examples

Table Key Downstream Customer in Other Therapeutic Applications

Figure United States Active Pharma Ingredient Market Size (Million USD) by Region (2012-2022)

Figure The West Active Pharma Ingredient Revenue (Million USD) and Growth Rate (2012-2022)

Figure Southwest Active Pharma Ingredient Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Middle Atlantic Active Pharma Ingredient Revenue (Million USD) and Growth Rate (2012-2022)

Figure New England Active Pharma Ingredient Revenue (Million USD) and Growth Rate (2012-2022)

Figure The South of US Active Pharma Ingredient Revenue (Million USD) and Growth Rate (2012-2022)

Figure The Midwest Active Pharma Ingredient Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Active Pharma Ingredient Sales (K Units) and Growth Rate (2012-2022)

Figure United States Active Pharma Ingredient Revenue (Million USD) and Growth Rate (2012-2022)

Figure United States Active Pharma Ingredient Market Major Players Product Sales Volume (K Units) (2012-2017)

Table United States Active Pharma Ingredient Sales (K Units) of Key Players/Suppliers (2012-2017)

Table United States Active Pharma Ingredient Sales Share by Players/Suppliers (2012-2017)

Figure 2016 United States Active Pharma Ingredient Sales Share by Players/Suppliers

Figure 2017 United States Active Pharma Ingredient Sales Share by Players/Suppliers

Figure United States Active Pharma Ingredient Market Major Players Product Revenue (Million USD) (2012-2017)

Table United States Active Pharma Ingredient Revenue (Million USD) by Players/Suppliers (2012-2017)

Table United States Active Pharma Ingredient Revenue Share by Players/Suppliers (2012-2017)

Figure 2016 United States Active Pharma Ingredient Revenue Share by Players/Suppliers

Figure 2017 United States Active Pharma Ingredient Revenue Share by Players/Suppliers

Table United States Market Active Pharma Ingredient Average Price (USD/Unit) of Key Players/Suppliers (2012-2017)

Figure United States Market Active Pharma Ingredient Average Price (USD/Unit) of Key Players/Suppliers in 2016

Figure United States Active Pharma Ingredient Market Share of Top 3 Players/Suppliers

Figure United States Active Pharma Ingredient Market Share of Top 5 Players/Suppliers

Table United States Players/Suppliers Active Pharma Ingredient Manufacturing Base Distribution and Sales Area

Table United States Players/Suppliers Active Pharma Ingredient Product Category

Table United States Active Pharma Ingredient Sales (K Units) by Region (2012-2017)

Table United States Active Pharma Ingredient Sales Share by Region (2012-2017)

Figure United States Active Pharma Ingredient Sales Share by Region (2012-2017)

Figure United States Active Pharma Ingredient Sales Market Share by Region in 2016

Table United States Active Pharma Ingredient Revenue (Million USD) and Market Share by Region (2012-2017)

Table United States Active Pharma Ingredient Revenue Share by Region (2012-2017)

Figure United States Active Pharma Ingredient Revenue Market Share by Region (2012-2017)

Figure United States Active Pharma Ingredient Revenue Market Share by Region in 2016

Table United States Active Pharma Ingredient Price (USD/Unit) by Region (2012-2017)

Table United States Active Pharma Ingredient Sales (K Units) by Type (2012-2017)

Table United States Active Pharma Ingredient Sales Share by Type (2012-2017)

Figure United States Active Pharma Ingredient Sales Share by Type (2012-2017)

Figure United States Active Pharma Ingredient Sales Market Share by Type in 2016

Table United States Active Pharma Ingredient Revenue (Million USD) and Market Share by Type (2012-2017)

Table United States Active Pharma Ingredient Revenue Share by Type (2012-2017)

Figure Revenue Market Share of Active Pharma Ingredient by Type (2012-2017)

Figure Revenue Market Share of Active Pharma Ingredient by Type in 2016

Table United States Active Pharma Ingredient Price (USD/Unit) by Types (2012-2017)

Figure United States Active Pharma Ingredient Sales Growth Rate by Type (2012-2017)

Table United States Active Pharma Ingredient Sales (K Units) by Application (2012-2017)

Table United States Active Pharma Ingredient Sales Market Share by Application (2012-2017)

Figure United States Active Pharma Ingredient Sales Market Share by Application (2012-2017)

Figure United States Active Pharma Ingredient Sales Market Share by Application in 2016

Table United States Active Pharma Ingredient Sales Growth Rate by Application (2012-2017)

Figure United States Active Pharma Ingredient Sales Growth Rate by Application (2012-2017)

Table Teva Basic Information List

Table Teva Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Teva Active Pharma Ingredient Sales Growth Rate (2012-2017)

Figure Teva Active Pharma Ingredient Sales Market Share in United States (2012-2017)

Figure Teva Active Pharma Ingredient Revenue Market Share in United States (2012-2017)

Table Novartis Basic Information List

Table Novartis Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Novartis Active Pharma Ingredient Sales Growth Rate (2012-2017)

Figure Novartis Active Pharma Ingredient Sales Market Share in United States (2012-2017)

Figure Novartis Active Pharma Ingredient Revenue Market Share in United States (2012-2017)

Table Pfizer Basic Information List

Table Pfizer Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Pfizer Active Pharma Ingredient Sales Growth Rate (2012-2017)

Figure Pfizer Active Pharma Ingredient Sales Market Share in United States (2012-2017)

Figure Pfizer Active Pharma Ingredient Revenue Market Share in United States (2012-2017)

Table Johnson & Johnson Basic Information List

Table Johnson & Johnson Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Johnson & Johnson Active Pharma Ingredient Sales Growth Rate (2012-2017)

Figure Johnson & Johnson Active Pharma Ingredient Sales Market Share in United States (2012-2017)

Figure Johnson & Johnson Active Pharma Ingredient Revenue Market Share in United States (2012-2017)

Table Mylan Basic Information List

Table Mylan Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Mylan Active Pharma Ingredient Sales Growth Rate (2012-2017)

Figure Mylan Active Pharma Ingredient Sales Market Share in United States (2012-2017)

Figure Mylan Active Pharma Ingredient Revenue Market Share in United States (2012-2017)

Table North China Pharmaceutical Group Basic Information List

Table North China Pharmaceutical Group Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure North China Pharmaceutical Group Active Pharma Ingredient Sales Growth Rate (2012-2017)

Figure North China Pharmaceutical Group Active Pharma Ingredient Sales Market Share in United States (2012-2017)

Figure North China Pharmaceutical Group Active Pharma Ingredient Revenue Market Share in United States (2012-2017)

Table Dr. Reddy’s Laboratories Basic Information List

Table Dr. Reddy’s Laboratories Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Dr. Reddy’s Laboratories Active Pharma Ingredient Sales Growth Rate (2012-2017)

Figure Dr. Reddy’s Laboratories Active Pharma Ingredient Sales Market Share in United States (2012-2017)

Figure Dr. Reddy’s Laboratories Active Pharma Ingredient Revenue Market Share in United States (2012-2017)

Table Roche Basic Information List

Table Roche Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Roche Active Pharma Ingredient Sales Growth Rate (2012-2017)

Figure Roche Active Pharma Ingredient Sales Market Share in United States (2012-2017)

Figure Roche Active Pharma Ingredient Revenue Market Share in United States (2012-2017)

Table Aurobindo pharma Basic Information List

Table Aurobindo pharma Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Aurobindo pharma Active Pharma Ingredient Sales Growth Rate (2012-2017)

Figure Aurobindo pharma Active Pharma Ingredient Sales Market Share in United States (2012-2017)

Figure Aurobindo pharma Active Pharma Ingredient Revenue Market Share in United States (2012-2017)

Table Sun Pharmaceutical Industries Basic Information List

Table Sun Pharmaceutical Industries Active Pharma Ingredient Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2012-2017)

Figure Sun Pharmaceutical Industries Active Pharma Ingredient Sales Growth Rate (2012-2017)

Figure Sun Pharmaceutical Industries Active Pharma Ingredient Sales Market Share in United States (2012-2017)

Figure Sun Pharmaceutical Industries Active Pharma Ingredient Revenue Market Share in United States (2012-2017)

Table Boehringer Ingelheim GmbH Basic Information List

Table Bayer Basic Information List

Table BASF Basic Information List

Table DSM Basic Information List

Table Zhejiang Medicine Basic Information List

Table Biocon Basic Information List

Table Johnson Matthey Basic Information List

Table Hisun Pharmacy Basic Information List

Table Cambrex Basic Information List

Table Shandong Xinhua Pharmaceutical Basic Information List

Table Lonza group Basic Information List

Table Huahai Pharmaceutical Basic Information List

Table Haerbin Pharmaceutical Group Basic Information List

Table Cipla Basic Information List

Table Tian Yao Basic Information List

Table Lupin Basic Information List

Table North East Pharmaceutical Basic Information List

Table Albemarle Basic Information List

Table Shandong Lukang Pharmaceutical Basic Information List

Table Jiangsu Hengrui Medicine Basic Information List

Table Production Base and Market Concentration Rate of Raw Material

Figure Price Trend of Key Raw Materials

Table Key Suppliers of Raw Materials

Figure Manufacturing Cost Structure of Active Pharma Ingredient

Figure Manufacturing Process Analysis of Active Pharma Ingredient

Figure Active Pharma Ingredient Industrial Chain Analysis

Table Raw Materials Sources of Active Pharma Ingredient Major Players/Suppliers in 2016

Table Major Buyers of Active Pharma Ingredient

Table Distributors/Traders List

Figure United States Active Pharma Ingredient Sales Volume (K Units) and Growth Rate Forecast (2017-2022)

Figure United States Active Pharma Ingredient Revenue (Million USD) and Growth Rate Forecast (2017-2022)

Figure United States Active Pharma Ingredient Price (USD/Unit) Trend Forecast (2017-2022)

Table United States Active Pharma Ingredient Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Active Pharma Ingredient Sales Volume (K Units) Forecast by Type (2017-2022)

Figure United States Active Pharma Ingredient Sales Volume (K Units) Forecast by Type in 2022

Table United States Active Pharma Ingredient Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Active Pharma Ingredient Sales Volume (K Units) Forecast by Application (2017-2022)

Figure United States Active Pharma Ingredient Sales Volume (K Units) Forecast by Application in 2022

Table United States Active Pharma Ingredient Sales Volume (K Units) Forecast by Region (2017-2022)

Table United States Active Pharma Ingredient Sales Volume Share Forecast by Region (2017-2022)

Figure United States Active Pharma Ingredient Sales Volume Share Forecast by Region (2017-2022)

Figure United States Active Pharma Ingredient Sales Volume Share Forecast by Region in 2022

Table Research Programs/Design for This Report

Figure Bottom-up and Top-down Approaches for This Report

Figure Data Triangulation

Table Key Data Information from Secondary Sources

Table Key Data Information from Primary Sources

 
Purchase Options

* Taxes/Fees, If applicable will be
added during checkout. All prices in USD.

Need More Information

Similar Reports

Protein Therapeutics Market by Product (Monoclonal Antibodies, Insulin, Fusion Protein, Erythropoietin, Interferon, Human Growth Hormone, and Follicle Stimulating Hormone) and Application (Metabolic Disorders, Immunologic Disorders, Hematological Disorders, Cancer, Hormonal Disorders, Genetic Disorders, and Others) - Global Opportunity Analysis and Industry Forecast, 2017-2023

Proteins that are designed and engineered in the laboratory for pharmaceutical interventions to treat different diseases are known as protein therapeutics. The global protein therapeutics market accounted for $140,109 million in 2016, and is anticipated to rea...

  • Publish Date: November 14, 2017
  • $5370
Global Cord Blood Banking Services (Stem Cell) Market, Size, Share, Trends, Forecast, Global Analysis, Research, Report, Segmentation, and Future Demand, 2012 - 2020

Umbilical cord blood bank is storage facility that collects cord blood after the childbirth from placenta. Cord blood is rich source of stem cell used in treatment of different chronic diseases. Private and public cord blood banks are the two major types of banks that are prevalent in th...

  • Publish Date: July 20, 2017
  • $5370